Clostridium Difficile Infections: New Drugs and New Strategies
Track:
Education Sessions (CE)
Program Code: 253-L01
Date: Tuesday, December 4, 2012
Time: 2:00 PM to 3:00 PM EST
Location:
South Seas D, Level 3, South Convention Center
PRESENTER:
Click the plus sign to see more detailed information about each speaker.
Kevin Garey, PharmD, MS, Associate Professor and Chair, University of Houston College of Pharmacy
Kevin Garey, PharmD, MS is an Associate Professor at the University of Houston College of Pharmacy and Chair of the Department of Clinical Sciences and Administration. He is an Adjunct Associate Professor at the University of Texas School of Public Health and a Clinical Specialist and Researcher at St. Lukes Episcopal Hospital, Houston, Texas. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health. Postdoctoral training includes a pharmacy practice residency at Bassett Healthcare, Cooperstown, NY and infectious disease specialty residency and fellowship training at the University of Illinois at Chicago, Chicago, IL. Dr. Garey's research interests involve clinical and translational research involving healthcare-associated infections including post-surgical infections, candidemia, and Clostridium difficile infection.
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
Kevin Garey, PharmD, MS, Associate Professor and Chair, University of Houston College of Pharmacy
Kevin Garey, PharmD, MS is an Associate Professor at the University of Houston College of Pharmacy and Chair of the Department of Clinical Sciences and Administration. He is an Adjunct Associate Professor at the University of Texas School of Public Health and a Clinical Specialist and Researcher at St. Lukes Episcopal Hospital, Houston, Texas. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health. Postdoctoral training includes a pharmacy practice residency at Bassett Healthcare, Cooperstown, NY and infectious disease specialty residency and fellowship training at the University of Illinois at Chicago, Chicago, IL. Dr. Garey's research interests involve clinical and translational research involving healthcare-associated infections including post-surgical infections, candidemia, and Clostridium difficile infection.
Describe methods to decrease the likelihood of CDI recurrence.
Develop a treatment plan for the first episode of CDI based on disease severity and underlying risk factors.
Identify modifiable risk factors that increase a patient's risk for C. difficile infection or CDI.